Journals / İzmir Atatürk Eğitim Hastanesi Tıp Dergisi / 2009 / Cilt: 47 - Sayı: 1

Tetanus

TETAN0Z

Pages
10–15
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, epidemiology, clinical features, therapy and prophylaxis of the disease is summarized with respect to literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tetanus is a disease that has still great importance, high mortality and morbidity rates.
📊
Key Findings & Data:Although in developing countries the disease is seen more frequently in newborns babies, children and adults, in developed countries geriatric people and intravenous drug users are at risk.
💡
Conclusion & Impact:In this review, epidemiology, clinical features, therapy and prophylaxis of the disease is summarized with respect to literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tetanus is a disease that has still great importance, high mortality and morbidity rates. Although in developing countries the disease is seen more frequently in newborns babies, children and adults, in developed countries geriatric people and intravenous drug users are at risk. Preventation of the disease by active immunization emphasizes the importance of routine immunization. In this review, epidemiology, clinical features, therapy and prophylaxis of the disease is summarized with respect to literature.

Özet

Tetanoz, günümüzde halen önemini koruyan, morbiditesi ve mortalitesi yüksek bir hastalıktır. Gelişmekte olan ülkelerde yenidoğanlar, çocuklar ve genç erişkinlerde daha sık görülürken, gelişmiş olan ülkelerde yaşlılar ve intravenöz ilaç kullanıcıları risk altındadır.Bu hastalığın aktif aşılama programı ile önlenebilir olması rutin aşılamanın önemini ortaya koymaktadır. Bu derlemede, literatür eşliğinde hastalığın epidemiyolojisi, klinik özellikleri, tedavi veprofilaksisi değerlendirilmiştir.

🔖

Cite This Article

TÜRKER, N., EL, S., ÖRMEN, B., KAPTAN, F. (2022). Tetanus. İzmir Atatürk Eğitim Hastanesi Tıp Dergisi, Cilt: 47 - Sayı: 1, 10–15. https://ajindex.com/articles/557488

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Arnon SS. Tetanus. In:Behrman RE, Kliegman RM, Arvin AM. Eds. Nelson Textbook of Pediatrics. 15th ed. Philadelphia: WB saunders 1996: 815 - 7
  2. Bleck T.P. Clostridium tetani (tetanus). In: Mandell GL, Bennet JE, Dolin R. Eds. Principles and Practice of Infectious Diseases. Elsevier Churchill Livingstone, sixty edition 2005: 2817 – 22
  3. Iqbal N. Tetanus in i.v. heroin users.Ann Saudi Med 2001; 21(5-6): 296 - 9. 4-Yalçın I, Palanduz A, Öneş Ü, Salman N, Güler N, Somer A. Yenidoğan tetanosu: 21 olgunun retrospektif değerlendirilmesi. Klimik Dergisi 1997;10;2: 73 - 5
  4. Tekeli E. Tetanoz. Topçu Wilke A, Söyletiler G, Doğanay M. Eds. Nobel Tıp kitabevi 2008: 1470- 6
  5. Zielinski A. Tetanus in 2005. Przegl Epidemiol 2007; 61(2): 287 - 9. 7- www.saglik.gov.tr. 1980 - 2006 yılları arası tetatoz vaka ve ölüm sayıları, morbidite ve mortalite oranları. 26/ 08 /2008
  6. Ergönül Ö, Erbay A, Eren S, Dokuzoğuz B. Analysis of the Case fatality Rate of Tetanus Among Adults in a Tertiary Hospital in Turkey. Eur. J Clin Microbiol İnfect Dis 2003; 22: 188 - 190
  7. Saltoğlu N, Taşova Y, Arslan A, Dündar İ.H. vaka ve ölüm sayıları, morbidite ve mortalite oranları. 26/ 08 /2008
  8. Ergönül Ö, Erbay A, Eren S, Dokuzoğuz B. Analysis of the Case fatality Rate of Tetanus Among Adults in a Tertiary Hospital in Turkey. Eur. J Clin Microbiol İnfect Dis 2003; 22: 188 - 190
  9. Saltoğlu N, Taşova Y, Arslan A, Dündar İ.H. Tetanoz olgularının immunizasyon öyküsü, klinik özellikleri, tedavi ve prognoz bakımından değerlendirilmesi. Klimik Dergisi 1997; 10: 2; 69 - 72
  10. Thomas PB. Tetanus; Pathophysiology, management, and prophylaxis.Dis Mon 1991; 37; 9: 545
  11. Freshwater-Turner D, Udy A, Lipman J, Deans R, Stuart J et al. Autonomic dysfunction in tetanus-what lessons can be learnt with specific reference to apha-2 agonists? Anaesthesia 2007; 62 (10):1066 - 70
  12. Mallick IH, Winslet MC. A review of the epidemiology, pathogenesis and manengement of tetanus. University Dept of Surgery, Royal Free and Universty Collage Medical School, London, UK. Int J Surg 2004; 2 (2):109 - 12
  13. Sharma VK, Dubey TN, Nayak R, Agarwal A. Cephalic tetanus with left infranuclear Facial palsy. J Assoc Physicians India 2007; 55: 735 - 6
  14. Odent M. Neonatal tetanus.Lancet 2008; 2;371:385 - 6
  15. Sutter RW, Orenstein WA, Wassilak SG. Tetanus. In: Hoeprich PD, Jordan MC, Ronald AR, eds. Infectious Diseases: A Modern Treatise of Infectious Processes. Fifth ed. Philadelphia: Lippincott 1994:1175